Bioorthogonal nanozymes for breast cancer imaging and therapy.

[1]  V. Rotello,et al.  Macrophage-Encapsulated Bioorthogonal Nanozymes for Targeting Cancer Cells , 2022, JACS Au.

[2]  V. Rotello,et al.  Degradable ZnS-Supported Bioorthogonal Nanozymes with Enhanced Catalytic Activity for Intracellular Activation of Therapeutics. , 2022, Journal of the American Chemical Society.

[3]  V. Rotello,et al.  Selective treatment of intracellular bacterial infections using host cell-targeted bioorthogonal nanozymes. , 2022, Materials Horizons.

[4]  Ana M. Pérez-López,et al.  A 5-FU Precursor Designed to Evade Anabolic and Catabolic Drug Pathways and Activated by Pd Chemistry In Vitro and In Vivo. , 2022, Journal of medicinal chemistry.

[5]  V. Rotello,et al.  Nanomaterial-based bioorthogonal nanozymes for biological applications. , 2021, Chemical Society reviews.

[6]  V. Rotello,et al.  Erythrocyte-mediated delivery of bioorthogonal nanozymes for selective targeting of bacterial infections. , 2021, Materials horizons.

[7]  V. Rotello,et al.  In situ activation of therapeutics through bioorthogonal catalysis. , 2021, Advanced drug delivery reviews.

[8]  T. Ward,et al.  Bioorthogonal strategies for the in vivo synthesis or release of drugs. , 2021, Bioorganic & medicinal chemistry.

[9]  Cheng-Jun Sun,et al.  Bioorthogonal catalytic patch , 2021, Nature Nanotechnology.

[10]  Jingyun Wang,et al.  Bioresorbable Depot for Sustained Release of Immunostimulatory Resiquimod in Suppressing Both Primary Triple-Negative Breast Tumors and Metastatic Occurrence. , 2021, Bioconjugate chemistry.

[11]  L. Do,et al.  Tools and Methods for Investigating Synthetic Metal-Catalyzed Reactions in Living Cells. , 2021, ACS catalysis.

[12]  V. Rotello,et al.  Lipophilicity of Cationic Ligands Promotes Irreversible Adsorption of Nanoparticles to Lipid Bilayers. , 2021, ACS nano.

[13]  G. Hudalla,et al.  Harnessing molecular recognition for localized drug delivery. , 2021, Advanced drug delivery reviews.

[14]  V. Rotello,et al.  Intracellular Activation of Anticancer Therapeutics Using Polymeric Bioorthogonal Nanocatalysts , 2020, Advanced healthcare materials.

[15]  A. Unciti-Broceta,et al.  Transition metal catalysts for the bioorthogonal synthesis of bioactive agents. , 2020, Current opinion in chemical biology.

[16]  B. Oliveira,et al.  Mechanistic insights into transition metal-mediated bioorthogonal uncaging reactions. , 2020, Chemical Society reviews.

[17]  X. Qu,et al.  Neutrophil-Membrane-Directed Bioorthogonal Synthesis of Inflammation-Targeting Chiral Drugs , 2020, Chem.

[18]  S. Zimmerman,et al.  A Bioorthogonal Small Molecule Selective Polymeric "Clickase". , 2020, Journal of the American Chemical Society.

[19]  Yugang Bai,et al.  Design and Engineering of Metal Catalysts for Bio-orthogonal Catalysis in Living Systems. , 2020, ACS applied bio materials.

[20]  V. Rotello,et al.  Polymer-Based Bioorthogonal Nanocatalyst for the Treatment of Bacterial Biofilms. , 2020, Journal of the American Chemical Society.

[21]  V. Rotello,et al.  Protection and Isolation of Bioorthogonal Metal Catalysts by Using Monolayer‐Coated Nanozymes , 2020, Chembiochem : a European journal of chemical biology.

[22]  V. Rotello,et al.  Thermally Gated Bio-orthogonal Nanozymes with Supramolecularly Confined Porphyrin Catalysts for Antimicrobial Uses , 2020, Chem.

[23]  Laura J Castellanos-García,et al.  Reconstruction, analysis, and segmentation of LA-ICP-MS imaging data using Python for the identification of sub-organ regions in tissues. , 2020, The Analyst.

[24]  V. Rotello,et al.  Intracellular Activation of Bioorthogonal Nanozymes through Endosomal Proteolysis of the Protein Corona. , 2020, ACS nano.

[25]  George van den Driessche,et al.  Adipocytes as Anticancer Drug Delivery Depot , 2019, Matter.

[26]  A. Awasthi,et al.  A Localized Chimeric Hydrogel Therapy Combats Tumor Progression through Alteration of Sphingolipid Metabolism , 2019, ACS central science.

[27]  Hao Wang,et al.  Site-Specific Construction of Long-Term Drug Depot for Suppression of Tumor Recurrence. , 2019, Small.

[28]  Katsunori Tanaka,et al.  Biocompatibility and therapeutic potential of glycosylated albumin artificial metalloenzymes , 2019, Nature Catalysis.

[29]  Asier Unciti-Broceta,et al.  Cancer-derived exosomes loaded with ultrathin palladium nanosheets for targeted bioorthogonal catalysis , 2019, Nature Catalysis.

[30]  R. Franzini,et al.  Dissociative Bioorthogonal Reactions , 2019, Chembiochem : a European journal of chemical biology.

[31]  J. Meyerhardt,et al.  5-Fluorouracil induced liver toxicity in patients with colorectal cancer: role of computed tomography texture analysis as a potential biomarker , 2019, Abdominal Radiology.

[32]  V. Rotello,et al.  Bioorthogonal nanozymes: progress towards therapeutic applications. , 2019, Trends in chemistry.

[33]  Hao Cheng,et al.  A Dual‐Bioresponsive Drug‐Delivery Depot for Combination of Epigenetic Modulation and Immune Checkpoint Blockade , 2019, Advanced materials.

[34]  Peter Y. Li,et al.  Engineering Protein Delivery Depots for Cancer Immunotherapy. , 2019, Bioconjugate chemistry.

[35]  Xiaogang Qu,et al.  Nanozymes: Classification, Catalytic Mechanisms, Activity Regulation, and Applications. , 2019, Chemical reviews.

[36]  V. Rotello,et al.  Control of Intra- versus Extracellular Bioorthogonal Catalysis Using Surface-Engineered Nanozymes. , 2018, ACS nano.

[37]  Jiangjiexing Wu,et al.  Nanomaterials with enzyme-like characteristics (nanozymes): next-generation artificial enzymes (II). , 2019, Chemical Society reviews.

[38]  Miles A. Miller,et al.  Modular Nanoparticulate Prodrug Design Enables Efficient Treatment of Solid Tumors Using Bioorthogonal Activation , 2018, ACS nano.

[39]  Salvador Pané,et al.  Mobile Magnetic Nanocatalysts for Bioorthogonal Targeted Cancer Therapy , 2018 .

[40]  D. Mooney,et al.  Replenishable drug depot to combat post-resection cancer recurrence. , 2018, Biomaterials.

[41]  N. Meanwell,et al.  The expanding role of prodrugs in contemporary drug design and development , 2018, Nature Reviews Drug Discovery.

[42]  X. Qu,et al.  Designed heterogeneous palladium catalysts for reversible light-controlled bioorthogonal catalysis in living cells , 2018, Nature Communications.

[43]  V. Rotello,et al.  Charge-Switchable Nanozymes for Bioorthogonal Imaging of Biofilm-Associated Infections. , 2017, ACS nano.

[44]  S. Mitragotri,et al.  A hyaluronic acid conjugate engineered to synergistically and sequentially deliver gemcitabine and doxorubicin to treat triple negative breast cancer , 2017, Journal of controlled release : official journal of the Controlled Release Society.

[45]  V. Rotello,et al.  Modulating the Catalytic Activity of Enzyme-like Nanoparticles Through their Surface Functionalization. , 2017, Molecular systems design & engineering.

[46]  Jarkko Rautio,et al.  Prodrugs in medicinal chemistry and enzyme prodrug therapies , 2017, Advanced drug delivery reviews.

[47]  Zelin Chen,et al.  A bioorthogonal nanosystem for imaging and in vivo tumor inhibition. , 2017, Biomaterials.

[48]  A. Zelikin,et al.  Substrate mediated enzyme prodrug therapy , 2017, Advanced drug delivery reviews.

[49]  Bo Yan,et al.  Dual-Mode Mass Spectrometric Imaging for Determination of in Vivo Stability of Nanoparticle Monolayers. , 2017, ACS nano.

[50]  Miles A. Miller,et al.  Nano-palladium is a cellular catalyst for in vivo chemistry , 2017, Nature Communications.

[51]  Annamaria Lilienkampf,et al.  In-Cell Dual Drug Synthesis by Cancer-Targeting Palladium Catalysts. , 2017, Angewandte Chemie.

[52]  Xiaohua Li,et al.  In vivo imaging of leucine aminopeptidase activity in drug-induced liver injury and liver cancer via a near-infrared fluorescent probe , 2017, Chemical science.

[53]  T. Tan,et al.  Photo-Modulated Therapeutic Protein Release from a Hydrogel Depot Using Visible Light. , 2017, Angewandte Chemie.

[54]  Nuria Oliva,et al.  Local triple-combination therapy results in tumour regression and prevents recurrence in a colon cancer model. , 2016, Nature materials.

[55]  S. Hou,et al.  Quantitative Differentiation of Cell Surface-Bound and Internalized Cationic Gold Nanoparticles Using Mass Spectrometry. , 2016, ACS nano.

[56]  Bo Yan,et al.  Surface Charge Controls the Suborgan Biodistributions of Gold Nanoparticles. , 2016, ACS nano.

[57]  Jie Li,et al.  Development and application of bond cleavage reactions in bioorthogonal chemistry. , 2016, Nature chemical biology.

[58]  Robert Langer,et al.  Emerging Frontiers in Drug Delivery. , 2016, Journal of the American Chemical Society.

[59]  Robert Langer,et al.  Bioresponsive materials , 2016 .

[60]  S. Hou,et al.  The Interplay of Size and Surface Functionality on the Cellular Uptake of Sub-10 nm Gold Nanoparticles. , 2015, ACS nano.

[61]  Sung Tae Kim,et al.  Supramolecular regulation of bioorthogonal catalysis in cells using nanoparticle-embedded transition metal catalysts. , 2015, Nature chemistry.

[62]  Samir Mitragotri,et al.  Overcoming the challenges in administering biopharmaceuticals: formulation and delivery strategies , 2014, Nature Reviews Drug Discovery.

[63]  S. Chankeshwara,et al.  Palladium-mediated chemistry in living cells. , 2014, Current opinion in chemical biology.

[64]  V. Rotello,et al.  The Role of Surface Functionality in Nanoparticle Exocytosis , 2014, Advanced healthcare materials.

[65]  John C. Dawson,et al.  Extracellular palladium-catalysed dealkylation of 5-fluoro-1-propargyl-uracil as a bioorthogonally activated prodrug approach , 2014, Nature Communications.

[66]  V. Rotello,et al.  Determination of the intracellular stability of gold nanoparticle monolayers using mass spectrometry. , 2012, Analytical chemistry.

[67]  M. Grinstaff,et al.  Local drug delivery strategies for cancer treatment: gels, nanoparticles, polymeric films, rods, and wafers. , 2012, Journal of controlled release : official journal of the Controlled Release Society.

[68]  H. Gelderblom,et al.  Chemotherapeutic adjuvant treatment for osteosarcoma: where do we stand? , 2011, European journal of cancer.

[69]  C. Bertozzi.  A decade of bioorthogonal chemistry. , 2011, Accounts of chemical research.

[70]  V. Rotello,et al.  Modulating Pharmacokinetics, Tumor Uptake and Biodistribution by Engineered Nanoparticles , 2011, PloS one.

[71]  Rahimi M. Yusop,et al.  Palladium-mediated intracellular chemistry. , 2011, Nature chemistry.

[72]  Miqin Zhang,et al.  Chitosan-based hydrogels for controlled, localized drug delivery. , 2010, Advanced drug delivery reviews.

[73]  E. Chu,et al.  Pharmacokinetically guided dose adjustment of 5-fluorouracil: a rational approach to improving therapeutic outcomes. , 2009, Journal of the National Cancer Institute.

[74]  Tycho Heimbach,et al.  Prodrugs: design and clinical applications , 2008, Nature Reviews Drug Discovery.

[75]  J. Karp,et al.  Nanocarriers as an Emerging Platform for Cancer Therapy , 2022 .

[76]  B. Thapa,et al.  Liver function tests and their interpretation , 2007, Indian journal of pediatrics.

[77]  P. Johnston,et al.  5-Fluorouracil: mechanisms of action and clinical strategies , 2003, Nature Reviews Cancer.